Patents by Inventor Jim Behling

Jim Behling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • L-ORNITHINE PHENYL ACETATE AND METHODS OF MAKING THEREOF
    Publication number: 20220162155
    Abstract: Disclosed herein are forms of L-ornithine phenyl acetate and methods of making the same. A crystalline form may, in some embodiments, be Forms I, II, III and V, or mixtures thereof. The crystalline forms may be formulated for treating subjects with liver disorders, such as hepatic encephalopathy. Accordingly, some embodiments include formulations and methods of administering L-ornithine phenyl acetate.
    Type: Application
    Filed: November 1, 2021
    Publication date: May 26, 2022
    Inventors: Keith Anderson, Jim Behling, Christine Henderson Dougan, Stephen William Watt, Peter Manini, Attilia Figini
  • L-ornithine phenyl acetate and methods of making thereof
    Patent number: 11161802
    Abstract: Disclosed herein are forms of L-ornithine phenyl acetate and methods of making the same. A crystalline form may, in some embodiments, be Forms I, II, III and V, or mixtures thereof. The crystalline forms may be formulated for treating subjects with liver disorders, such as hepatic encephalopathy. Accordingly, some embodiments include formulations and methods of administering L-ornithine phenyl acetate.
    Type: Grant
    Filed: January 31, 2020
    Date of Patent: November 2, 2021
    Assignee: Ocera Therapeutics, Inc.
    Inventors: Keith Anderson, Jim Behling, Christine Henderson Dougan, Stephen William Watt, Peter Manini, Attilia Figini
  • L-ORNITHINE PHENYL ACETATE AND METHODS OF MAKING THEREOF
    Publication number: 20200239406
    Abstract: Disclosed herein are forms of L-ornithine phenyl acetate and methods of making the same. A crystalline form may, in some embodiments, be Forms I, II, III and V, or mixtures thereof. The crystalline forms may be formulated for treating subjects with liver disorders, such as hepatic encephalopathy. Accordingly, some embodiments include formulations and methods of administering L-ornithine phenyl acetate.
    Type: Application
    Filed: January 31, 2020
    Publication date: July 30, 2020
    Inventors: Keith Anderson, Jim Behling, Christine Henderson Dougan, Stephen William Watt, Peter Manini, Attilia Figini
  • L-ornithine phenyl acetate and methods of making thereof
    Patent number: 10550069
    Abstract: Disclosed herein are forms of L-ornithine phenyl acetate and methods of making the same. A crystalline form may, in some embodiments, be Forms I, II, III and V, or mixtures thereof. The crystalline forms may be formulated for treating subjects with liver disorders, such as hepatic encephalopathy. Accordingly, some embodiments include formulations and methods of administering L-ornithine phenyl acetate.
    Type: Grant
    Filed: July 17, 2018
    Date of Patent: February 4, 2020
    Assignee: Ocera Therapeutics, Inc.
    Inventors: Keith E. Anderson, Jim Behling, Christine Henderson Dougan, Stephen William Watt, Peter Manini, Attilia Figini
  • L-ornithine phenyl acetate and methods of making thereof
    Patent number: 10173964
    Abstract: Disclosed herein are forms of L-ornithine phenyl acetate and methods of making the same. A crystalline form may, in some embodiments, be Forms I, II, III and V, or mixtures thereof. The crystalline forms may be formulated for treating subjects with liver disorders, such as hepatic encephalopathy. Accordingly, some embodiments include formulations and methods of administering L-ornithine phenyl acetate.
    Type: Grant
    Filed: March 24, 2017
    Date of Patent: January 8, 2019
    Assignee: Ocera Therapeutics, Inc.
    Inventors: Keith E. Anderson, Jim Behling, Christine Henderson Dougan, Stephen William Watt, Peter Manini, Attilia Figini
  • L-ORNITHINE PHENYL ACETATE AND METHODS OF MAKING THEREOF
    Publication number: 20180319736
    Abstract: Disclosed herein are forms of L-ornithine phenyl acetate and methods of making the same. A crystalline form may, in some embodiments, be Forms I, II, III and V, or mixtures thereof. The crystalline forms may be formulated for treating subjects with liver disorders, such as hepatic encephalopathy. Accordingly, some embodiments include formulations and methods of administering L-ornithine phenyl acetate.
    Type: Application
    Filed: July 17, 2018
    Publication date: November 8, 2018
    Inventors: Keith E. Anderson, Jim Behling, Christine Henderson Dougan, Stephen William Watt, Peter Manini, Attilia Figini
  • L-ORNITHINE PHENYL ACETATE AND METHODS OF MAKING THEREOF
    Publication number: 20180044281
    Abstract: Disclosed herein are forms of L-ornithine phenyl acetate and methods of making the same. A crystalline form may, in some embodiments, be Forms I, II, III and V, or mixtures thereof. The crystalline forms may be formulated for treating subjects with liver disorders, such as hepatic encephalopathy. Accordingly, some embodiments include formulations and methods of administering L-ornithine phenyl acetate.
    Type: Application
    Filed: March 24, 2017
    Publication date: February 15, 2018
    Inventors: Keith E. Anderson, Jim Behling, Christine Henderson Dougan, Stephen William Watt, Peter Manini, Attilia Figini
  • L-ornithine phenyl acetate and methods of making thereof
    Patent number: 9604909
    Abstract: Disclosed herein are forms of L-ornithine phenyl acetate and methods of making the same. A crystalline form may, in some embodiments, be Forms I, II, III and V, or mixtures thereof. The crystalline forms may be formulated for treating subjects with liver disorders, such as hepatic encephalopathy. Accordingly, some embodiments include formulations and methods of administering L-ornithine phenyl acetate.
    Type: Grant
    Filed: May 18, 2015
    Date of Patent: March 28, 2017
    Assignee: Ocera Therapeutics, Inc.
    Inventors: Keith Anderson, Jim Behling, Christine Henderson Dougan, Stephen William Watt, Peter Manini, Attilia Figini
  • Methods of making L-ornithine phenyl acetate
    Patent number: 9260379
    Abstract: Disclosed herein are processes for making L-ornithine phenyl acetate. The process may include, for example, intermixing a halide salt of L-ornithine with silver phenyl acetate. The process may also include forming a phenyl acetate salt in situ. The present application also relates to various compositions obtained from these processes, including crystalline forms.
    Type: Grant
    Filed: January 21, 2015
    Date of Patent: February 16, 2016
    Assignee: Ocera Therapeutics, Inc.
    Inventors: Keith E. Anderson, Jim Behling, Christine Henderson Dougan, Stephen William Watt, Peter Manini, Attilia Figini
  • L-ORNITHINE PHENYL ACETATE AND METHODS OF MAKING THEREOF
    Publication number: 20150251990
    Abstract: Disclosed herein are forms of L-ornithine phenyl acetate and methods of making the same. A crystalline form may, in some embodiments, be Forms I, II, III and V, or mixtures thereof. The crystalline forms may be formulated for treating subjects with liver disorders, such as hepatic encephalopathy. Accordingly, some embodiments include formulations and methods of administering L-ornithine phenyl acetate.
    Type: Application
    Filed: May 18, 2015
    Publication date: September 10, 2015
    Inventors: Keith Anderson, Jim Behling, Christine Henderson Dougan, Stephen William Watt, Peter Manini, Attilia Figini
  • L-ornithine phenyl acetate and methods of making thereof
    Patent number: 9034925
    Abstract: Disclosed herein are forms of L-ornithine phenyl acetate and methods of making the same. A crystalline form may, in some embodiments, be Forms I, II, III and V, or mixtures thereof. The crystalline forms may be formulated for treating subjects with liver disorders, such as hepatic encephalopathy. Accordingly, some embodiments include formulations and methods of administering L-ornithine phenyl acetate.
    Type: Grant
    Filed: June 9, 2014
    Date of Patent: May 19, 2015
    Assignee: Ocera Therapeutics, Inc.
    Inventors: Keith Anderson, Jim Behling, Christine Henderson Dougan, Stephen William Watt, Peter Manini, Attilia Figini
  • METHODS OF MAKING L-ORNITHINE PHENYL ACETATE
    Publication number: 20150133684
    Abstract: Disclosed herein are processes for making L-ornithine phenyl acetate. The process may include, for example, intermixing a halide salt of L-ornithine with silver phenyl acetate. The process may also include forming a phenyl acetate salt in situ. The present application also relates to various compositions obtained from these processes, including crystalline forms.
    Type: Application
    Filed: January 21, 2015
    Publication date: May 14, 2015
    Inventors: Keith H. Anderson, Jim Behling, Christine Henderson Dougan, Stephen William Watt, Peter Manini, Attilia Figini
  • Methods of making L-ornithine phenyl acetate
    Patent number: 8946473
    Abstract: Disclosed herein are processes for making L-ornithine phenyl acetate. The process may include, for example, inter-mixing a halide salt of L-ornithine with silver phenyl acetate. The process may also include forming a phenyl acetate salt in situ. The present application also relates to various compositions obtained from these processes, including crystalline forms.
    Type: Grant
    Filed: October 5, 2011
    Date of Patent: February 3, 2015
    Assignee: Ocera Therapeutics, Inc.
    Inventors: Keith H. Anderson, Jim Behling, Christine Henderson Dougan, Stephen William Watt, Peter Manini, Attilia Figini
  • L-ORNITHINE PHENYL ACETATE AND METHODS OF MAKING THEREOF
    Publication number: 20140288327
    Abstract: Disclosed herein are forms of L-ornithine phenyl acetate and methods of making the same. A crystalline form may, in some embodiments, be Forms I, II, III and V, or mixtures thereof. The crystalline forms may be formulated for treating subjects with liver disorders, such as hepatic encephalopathy. Accordingly, some embodiments include formulations and methods of administering L-ornithine phenyl acetate.
    Type: Application
    Filed: June 9, 2014
    Publication date: September 25, 2014
    Inventors: Keith Anderson, Jim Behling, Christine Henderson Dougan, Stephen William Watt, Peter Manini, Attilia Figini
  • L-ornithine phenyl acetate and methods of making thereof
    Patent number: 8785498
    Abstract: Disclosed herein are forms of L-ornithine phenyl acetate and methods of making the same. A crystalline form may, in some embodiments, be Forms I, II, III and V, or mixtures thereof. The crystalline forms may be formulated for treating subjects with liver disorders, such as hepatic encephalopathy. Accordingly, some embodiments include formulations and methods of administering L-ornithine phenyl acetate.
    Type: Grant
    Filed: July 8, 2013
    Date of Patent: July 22, 2014
    Assignee: Ocera Therapeutics, Inc.
    Inventors: Keith Anderson, Jim Behling, Christine Henderson Dougan, Stephen William Watt, Peter Manini, Attilia Figini
  • L-ORNITHINE PHENYL ACETATE AND METHODS OF MAKING THEREOF
    Publication number: 20130296429
    Abstract: Disclosed herein are forms of L-ornithine phenyl acetate and methods of making the same. A crystalline form may, in some embodiments, be Forms I, II, III and V, or mixtures thereof. The crystalline forms may be formulated for treating subjects with liver disorders, such as hepatic encephalopathy. Accordingly, some embodiments include formulations and methods of administering L-ornithine phenyl acetate.
    Type: Application
    Filed: July 8, 2013
    Publication date: November 7, 2013
    Inventors: Keith Anderson, Jim Behling, Christine Henderson Dougan, Stephen William Watt, Peter Manini, Attilia Figini
  • METHODS OF MAKING L-ORNITHINE PHENYL ACETATE
    Publication number: 20130211135
    Abstract: Disclosed herein are processes for making L-ornithine phenyl acetate. The process may include, for example, inter-mixing a halide salt of L-ornithine with silver phenyl acetate. The process may also include forming a phenyl acetate salt in situ. The present application also relates to various compositions obtained from these processes, including crystalline forms.
    Type: Application
    Filed: October 5, 2011
    Publication date: August 15, 2013
    Applicant: Ocera Therapeutics, Inc.
    Inventors: Keith H. Anderson, Jim Behling, Christine Henderson Dougan, Stephen William Watt, Peter Manini, Attilia Figini
  • L-ornithine phenyl acetate and methods of making thereof
    Patent number: 8492439
    Abstract: Disclosed herein are forms of L-ornithine phenyl acetate and methods of making the same. A crystalline form may, in some embodiments, be Forms I, II, III and V, or mixtures thereof. The crystalline forms may be formulated for treating subjects with liver disorders, such as hepatic encephalopathy. Accordingly, some embodiments include formulations and methods of administering L-ornithine phenyl acetate.
    Type: Grant
    Filed: March 30, 2012
    Date of Patent: July 23, 2013
    Assignee: Ocera Therapeutics, Inc.
    Inventors: Keith Anderson, Jim Behling, Christine Henderson Dougan, Stephen William Watt, Peter Manini, Attilia Figini
  • L-ORNITHINE PHENYL ACETATE AND METHODS OF MAKING THEREOF
    Publication number: 20120208885
    Abstract: Disclosed herein are forms of L-ornithine phenyl acetate and methods of making the same. A crystalline form may, in some embodiments, be Forms I, II, III and V, or mixtures thereof. The crystalline forms may be formulated for treating subjects with liver disorders, such as hepatic encephalopathy. Accordingly, some embodiments include formulations and methods of administering L-ornithine phenyl acetate.
    Type: Application
    Filed: March 30, 2012
    Publication date: August 16, 2012
    Applicant: OCERA THERAPEUTICS, INC.
    Inventors: Keith Anderson, Jim Behling, Christine Henderson Dougan, Stephen William Watt, Peter Manini, Attilia Figini
  • L-ornithine phenyl acetate and methods of making thereof
    Patent number: 8173706
    Abstract: Disclosed herein are crystalline forms of L-ornithine phenyl acetate and methods of making the same. The crystalline form may, in some embodiments, be Forms I, II, III and V, or mixtures thereof. The crystalline forms may be formulated for treating subjects with liver disorders, such as hepatic encephalopathy. Accordingly, some embodiments include formulations and methods of administering L-ornithine phenyl acetate.
    Type: Grant
    Filed: April 2, 2010
    Date of Patent: May 8, 2012
    Assignee: Ocera Therapeutics, Inc.
    Inventors: Keith Anderson, Jim Behling, Christine Henderson Dougan, Stephen William Watt, Peter Manini, Attilia Figini